Opinion|Videos|November 8, 2024
Looking Ahead: Anticipating Changes in Lupus Guidelines and Clinical Practice
Author(s)Amit Saxena, MD
Key Takeaways
- Individual patient characteristics, such as disease severity and comorbidities, significantly influence lupus nephritis treatment decisions.
- Steroid use requires careful balancing to maximize efficacy while minimizing adverse effects in lupus nephritis management.
Amit Saxena, MD, discusses how personalized treatment decisions for lupus nephritis require careful consideration of patient characteristics, multidisciplinary coordination, and emerging guidelines, while acknowledging both the opportunities and challenges that lie ahead in clinical practice.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What considerations (eg, individual patient characteristics, steroid use, drug interactions) guide your treatment choices for managing lupus nephritis?
- How important is multidisciplinary care in managing lupus nephritis, and how do you coordinate this?
- The ACR is working on a 2-part lupus guideline project expected next year. In what ways do you see these guidelines evolving in the future?
- What specific opportunities or challenges do you see on the horizon for managing lupus nephritis in practice?
Advertisement
Related to this article
The Autus Size-Adjustable Valve, which can be expanded as children grow, may reduce the need for repeat open-heart surgeries for congenital defects.
Phase 3 wins for ianalumab and dazodalibep bring targeted therapies closer for Sjögren disease as patients face diagnostic delays and high costs.
Although PMOS Awareness Month has ended, the conversation continues, with experts saying closing diagnostic and care gaps requires ongoing efforts.
Invivyd's VYD2311 shows superior safety and tolerability vs Comirnaty in the phase 3 LIBERTY trial, with no vaccine interference.
Survodutide achieved up to 13.1% weight loss vs 3.1% with placebo at 76 weeks in adults with obesity and T2D in the phase 3 SYNCHRONIZE-2 trial.
A rare case of soft-tissue sarcoma spreading to the heart shows how multimodal imaging guided diagnosis and care in a 36-year-old man.
Weekend catch-up sleep was associated with lower odds of overactive bladder and milder symptoms, with the benefit concentrated in the first 1.5 hours.
Advertisement
Advertisement
Trending on AJMC
1
Systemic Sclerosis Linked to Dramatic Rise in Lung Cancer Risk
2
FDA Approves First Heart Valve to Keep Pace With Children's Growth
3
Psoriasis Is Much Rarer in Indigenous Groups Worldwide
4
Traditional Medicare OOP Cap Could Lower Costs, Raise Federal Spending
5